课题基金 / 基金详情

Definition of human intestinal mesenchymal origins and of mesenchymal epithelial cross-talk in health and disease

Definition of human intestinal mesenchymal origins and of mesenchymal epithelial cross-talk in health and disease
人类肠道间充质起源以及健康和疾病中间充质上皮串扰的定义
批准号:
MR/S036377/1
负责人:
Alison Simmons
金额:
$36.1万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2018
资助国家:
英国
项目状态:
已结题
起止时间:
2018 至 --

项目摘要

项目成果

Alison Simmons的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cells such as fibroblasts and smooth muscle cells provide critical structural support in organs such as the gut. Over the last 10 years it has become apparent that these cells play important and diverse cellular functions during embryonic development and in the steady state adult intestine. In addition to their structural roles these cells send signals that control the level of immune cell activity. They also signal to the cells lining the surface of the gut, epithelial cells, to ensure they grow to provide a healthy barrier between the intestinal tissue and the gut microbes. We previously used new state of the art single cell technologies (single-cell RNA-sequencing) to measure genes expressed within single mesenchymal cells isolated from human or mouse colonic mesenchyme in health or during colitis. This revealed the surprising observation of several new cell types within what was previously thought to be one population. We went onto explore these new mesenchymal cell states and demonstrated differing functions and anatomical location within the colonic tissue. The study enabled us to identify which cells in the mesenchyme act as a niche for intestinal epithelial stem cells producing factors required for their differentiation and formation of the epithelial barrier layer of the colon. In colitis we identified important changes in single mesenchymal cells including in emergence of a highly activated population that expressed factors that attract immune cells and factors that impair epithelial function. Abnormal expansion of these disease-associated cells contributes to inflammation observed in diseases such as inflammatory bowel disease. These structural cells also play important roles in intestinal fibrosis, when they produce too much matrix protein that makes tissues stiff and leads to strictures in the intestine that prevent the passage of food and require surgery. Furthermore they play important roles in cancer, fuelling invasiveness and metastatic behaviour in colon cancer. Despite their newly identified and important roles in colon physiology and disease little is known of how these cells arise either in human development or adult state. Little is known about how these cells differentiate into different types and how they control anatomical location of different epithelial cells such as stem cells lining the gut. It is important to identify mesenchymal precursor cells and define the molecular determinants that control emergence of pathogenic populations to revert their aberrant behaviour in disease. Furthermore better understanding of mesenchymal progenitors would enable development of organ-on a chip systems to model human intestine during drug development and enable regenerative medicine approaches for gastrointestinal disease. In this work we will use both single-cell RNA-sequencing and spatial imaging to map human foetal development of colonic mesenchymal cells and the associated colonic epithelial layer with a view to defining a mesenchymal progenitor cell and the molecular cross-talk between mesenchymal and epithelia that dictates formation of healthy barrier. We will use the same approach to define how this relationship breaks down to drive pathology in IBD and colorectal cancer. We will use the foetal development data to inform a search for the colonic mesenchymal stem cell in adult tissue and define functionally if such a cell type exists. This work is critical for advancement of treatments targeting the barrier in both developmental and adult colonic diseases.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
Baseline Expression of Immune Gene Modules in Blood is Associated With Primary Response to Anti-TNF Therapy in Crohn's Disease Patients.
血液中免疫基因模块的基线表达与克罗恩病患者对抗 TNF 治疗的主要反应相关。
DOI: 10.1093/ecco-jcc/jjad166
发表时间: 2024
期刊: Journal of Crohn's & colitis
影响因子: --
作者: [Bai BYH]
通讯作者: Bai BYH
DOI: 10.1053/j.gastro.2021.05.059
发表时间: 2021-08-18
期刊: GASTROENTEROLOGY
影响因子: 29.4
作者: [Ali, Sharib, Bailey, Adam, Braden, Barbara]
通讯作者: Braden, Barbara
HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44+ Natural Killer Cells in Ulcerative Colitis.
上皮细胞上的 HLA-DP 可导致溃疡性结肠炎中 NKp44 自然杀伤细胞造成组织损伤。
DOI: 10.1053/j.gastro.2023.06.034
发表时间: 2023
期刊: Gastroenterology
影响因子: 29.4
作者: [Baumdick,MartinE, Niehrs,Annika, Degenhardt,Frauke, Schwerk,Maria, Hinrichs,Ole, Jordan-Paiz,Ana, Padoan,Benedetta, Wegner,LucyHM, Schloer,Sebastian, Zecher,BrittaF, Malsy,Jakob, Joshi,VinitaR, Illig,Christin, Schröder-Schwarz,Jennifer, ]
通讯作者:
DOI: 10.1038/s42003-022-03038-z
发表时间: 2022-02-04
期刊: Communications biology
影响因子: 5.9
作者: [Aulicino A, Antanaviciute A, Frost J, Sousa Geros A, Mellado E, Attar M, Jagielowicz M, Hublitz P, Sinz J, Preciado-Llanes L, Napolitani G, Bowden R, Koohy H, Drakesmith H, Simmons A]
通讯作者: Simmons A
7
    Intestinal Immunity in health and disease
    • 批准号:
      MC_UU_00036/1
    • 项目类别:
      Intramural
    • 资助金额:
      $309.63万
    • 财政年份:
      2023
    • 负责人:
      Alison Simmons
    • 依托单位:
    Disruption of a T cell recruitment and retention gradient for the treatment of chronic intestinal inflammation in inflammatory bowel disease
    • 批准号:
      MC_PC_MR/S025952/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $0.77万
    • 财政年份:
      2019
    • 负责人:
      Alison Simmons
    • 依托单位:
    Immunology of Digestive Disease
    • 批准号:
      MC_UU_00008/7
    • 项目类别:
      Intramural
    • 资助金额:
      $51.1万
    • 财政年份:
      2017
    • 负责人:
      Alison Simmons
    • 依托单位:
    国内基金
    海外基金
    靶向Human ZAG蛋白的降糖小分子化合物筛选以及疗效观察
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      胡文静
    • 依托单位:
    新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
    • 批准号:
      82370885
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      姚晨
    • 依托单位:
    自闭症相关基因CHD8在非人灵长类大脑发育中的作用
    HBV S-Human ESPL1融合基因在慢性乙型肝炎发病进程中的分子机制研究
    • 批准号:
      81960115
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      34.0万元
    • 批准年份:
      2019
    • 负责人:
      江建宁
    • 依托单位: